Treatment in heart failure and hemodialysis: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
m (Bot: Adding CME Category::Cardiology) |
||
| Line 10: | Line 10: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[CME Category::Cardiology]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
| Line 15: | Line 19: | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Up-To-Date cardiology]] | [[Category:Up-To-Date cardiology]] | ||
Revision as of 18:57, 14 March 2016
Template:Hypercholesterolemia Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Heart Failure and Hemodialysis
No recommendation was made regarding the initiation or continuation of statin therapy in 2 specific groups[1]:
- Individuals with NYHA class II–IV heart failure
- Individuals undergoing maintenance hemodialysis.
References
- ↑ "2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults". Retrieved 13 November 2013.